We are live on ! Find out more
TIL icon

Instil Bio

62 hedge funds and large institutions have $1.35B invested in Instil Bio in 2021 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 5

29% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 21

11% more funds holding

Funds holding: 5662 (+6)

0.15% more ownership

Funds ownership: 2.58%2.74% (+0.15%)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

17% less capital invested

Capital invested by funds: $1.62B → $1.35B (-$271M)

Holders
62
Holders Change
+6
Holders Change %
+10.71%
% of All Funds
1.08%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
27
Increased
17
Reduced
5
Closed
21
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PHK
76
Point72 Hong Kong
Hong Kong
-$265K -528 Closed
DKCM
77
Davidson Kempner Capital Management
New York
-$254K -500 Closed
MS
78
Maven Securities
Jersey
-$250K -481 Closed
Squarepoint
79
Squarepoint
New York
-$240K -478 Closed
ECM
80
ExodusPoint Capital Management
New York
-$231K -460 Closed
M&T Bank
81
M&T Bank
New York
-$202K -402 Closed
RCMU
82
Rokos Capital Management (UK)
United Kingdom
-$75K -150 Closed
FMT
83
First Mercantile Trust
Tennessee
-$35K -70 Closed

TIL Hedge Fund Activity: Q2 2021 in Review

62 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2021, worth a combined $1.35B — down 17% from $1.62B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new TIL positions and 21 closed out — a net gain of 6 holders — while 17 added to existing stakes and 5 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $67M. The largest seller was Wellington Management Group, cutting an estimated $30.6M.

  • 62 institutional investors held Instil Bio (TIL) as of Q2 2021, up from 56 in Q1 2021.
  • Funds reported $1.35B of Instil Bio stock for Q2 2021, down 17% quarter-over-quarter.
  • 27 funds opened new Instil Bio positions in Q2 2021 and 21 closed out, a net change of +6 holders.
  • The largest Instil Bio buyer in Q2 2021 was Fidelity Investments, an estimated $67M added.
  • The largest Instil Bio seller in Q2 2021 was Wellington Management Group, an estimated $30.6M sold.

Based on aggregated 13F filings for Q2 2021.